Key result
PCB troponin assay shows ~99% consistency with standard ELISA across serum, saliva, and urine samples.
Why the study?
Does the PCB assay accurately detect cardiac troponin in non-invasive samples like saliva or urine compared to ELISA?
Observational (n=100)
Does the PCB assay accurately detect cardiac troponin in non-invasive samples like saliva or urine compared to ELISA?
Answers are grounded in this paper and cite their sources.
A novel PCB assay can rapidly and reliably detect cardiac troponin in non-invasive samples like saliva and urine, showing near-perfect consistency with standard ELISA.
). Owing to the hydrodynamic enrichment of the PCB, 10 μL of sample can be measured, minimizing interference from impurities in body fluids and human sampling errors. We used 100 clinical samples, including serum, saliva, and urine, to verify the reliability of the PCB assay; compared with ELISA, the PCB assay exhibited consistencies of 0.998, 0.999, and 0.999, respectively. Notably, monitoring the saliva of a patient with an AMI history using the PCB assay enables rapid therapeutic intervention within 30 minutes. The PCB was first used for non-invasive body fluid testing to provide reliable results for clinical diagnosis, with the potential to provide AMI health promotion.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2025) conducted an observational in Acute myocardial infarction (n=100). PCB assay for cardiac troponin detection vs. ELISA was evaluated on Consistency with ELISA (consistencies of 0.998, 0.999, and 0.999). The PCB assay for cardiac troponin detection exhibited consistencies of 0.998, 0.999, and 0.999 compared with ELISA for serum, saliva, and urine samples, respectively.
Synapse has enriched 10 related papers. Consider them for comparative context: